221 related articles for article (PubMed ID: 26216968)
21. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
[TBL] [Abstract][Full Text] [Related]
22. An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation.
Miller MS; Douglass J; Hwang MS; Skora AD; Murphy M; Papadopoulos N; Kinzler KW; Vogelstein B; Zhou S; Gabelli SB
J Biol Chem; 2019 Dec; 294(50):19322-19334. PubMed ID: 31690625
[TBL] [Abstract][Full Text] [Related]
23. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
[TBL] [Abstract][Full Text] [Related]
24. Selection and characterization of human serum albumin-specific porcine scFv antibodies using a phage display library.
Muraoka J; Ozawa T; Enomoto Y; Kiyose N; Imamura A; Arima K; Nakayama H; Ito Y
Monoclon Antib Immunodiagn Immunother; 2014 Feb; 33(1):42-8. PubMed ID: 24555936
[TBL] [Abstract][Full Text] [Related]
25. Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor.
Tassev DV; Cheng M; Cheung NK
Cancer Gene Ther; 2012 Feb; 19(2):84-100. PubMed ID: 21979579
[TBL] [Abstract][Full Text] [Related]
26. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
Robbins PA; Lettice LA; Rota P; Santos-Aguado J; Rothbard J; McMichael AJ; Strominger JL
J Immunol; 1989 Dec; 143(12):4098-103. PubMed ID: 2480387
[TBL] [Abstract][Full Text] [Related]
27. Hybrid genes between HLA-A2 and HLA-A3 constructed by in vivo recombination allow mapping of HLA-A2 and HLA-A3 polymorphic antigenic determinants.
Sire J; Chimini G; Boretto J; Toubert A; Kahn-Perles B; Layet C; Sodoyer R; Lemonnier F; Jordan B
J Immunol; 1988 Apr; 140(7):2422-30. PubMed ID: 2450922
[TBL] [Abstract][Full Text] [Related]
28. Single-chain variable fragment (scFv) antibodies optimized for environmental analysis of uranium.
Zhu X; Kriegel AM; Boustany CA; Blake DA
Anal Chem; 2011 May; 83(10):3717-24. PubMed ID: 21473651
[TBL] [Abstract][Full Text] [Related]
29. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.
Chaux P; Luiten R; Demotte N; Vantomme V; Stroobant V; Traversari C; Russo V; Schultz E; Cornelis GR; Boon T; van der Bruggen P
J Immunol; 1999 Sep; 163(5):2928-36. PubMed ID: 10453041
[TBL] [Abstract][Full Text] [Related]
30. Creation of an HLA-A2/HLA-Aw69 alloantigenic determinant on an HLA-A3 molecule by site-directed mutagenesis.
Layet C; Kahn-Perles B; Pontarotti P; Ferrier P; Sire J; Lemonnier FA
J Immunol; 1987 Apr; 138(7):2197-201. PubMed ID: 2435791
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the molecular basis of HLA-A3 recognition by cytotoxic T cells using defined mutants of the HLA-A3 molecule.
Jelachich ML; Cowan EP; Turner RV; Coligan JE; Biddison WE
J Immunol; 1988 Aug; 141(4):1108-13. PubMed ID: 2456340
[TBL] [Abstract][Full Text] [Related]
32. Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells.
Gricks CS; Rawlings E; Foroni L; Madrigal JA; Amlot PL
Cancer Res; 2001 Jul; 61(13):5145-52. PubMed ID: 11431353
[TBL] [Abstract][Full Text] [Related]
33. HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes.
Gjertsen MK; Saeterdal I; Saebøe-Larssen S; Gaudernack G
J Mol Med (Berl); 2003 Jan; 81(1):43-50. PubMed ID: 12545248
[TBL] [Abstract][Full Text] [Related]
34. Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H.
Inaguma Y; Akahori Y; Murayama Y; Shiraishi K; Tsuzuki-Iba S; Endoh A; Tsujikawa J; Demachi-Okamura A; Hiramatsu K; Saji H; Yamamoto Y; Yamamoto N; Nishimura Y; Takahashi T; Kuzushima K; Emi N; Akatsuka Y
Gene Ther; 2014 Jun; 21(6):575-84. PubMed ID: 24694533
[TBL] [Abstract][Full Text] [Related]
35. Overlapping epitopes encompassing a point mutation (12 Gly-->Arg) in p21 ras can be recognized by HLA-DR, -DP and -DQ restricted T cells.
Fossum B; Gedde-Dahl T; Hansen T; Eriksen JA; Thorsby E; Gaudernack G
Eur J Immunol; 1993 Oct; 23(10):2687-91. PubMed ID: 7691613
[TBL] [Abstract][Full Text] [Related]
36. Immunological characterization of missense mutations occurring within cytotoxic T cell-defined p53 epitopes in HLA-A*0201+ squamous cell carcinomas of the head and neck.
Ito D; Visus C; Hoffmann TK; Balz V; Bier H; Appella E; Whiteside TL; Ferris RL; DeLeo AB
Int J Cancer; 2007 Jun; 120(12):2618-24. PubMed ID: 17294448
[TBL] [Abstract][Full Text] [Related]
37. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
38. The ability of cytotoxic T cells to recognize HLA-A2.1 or HLA-B7 antigens expressed on murine cells correlates with their epitope specificity.
Bernhard EJ; Le AX; Yannelli JR; Holterman MJ; Hogan KT; Parham P; Engelhard VH
J Immunol; 1987 Dec; 139(11):3614-21. PubMed ID: 2445816
[TBL] [Abstract][Full Text] [Related]
39. Improvement of anti-Burkholderia mouse monoclonal antibody from various phage-displayed single-chain antibody libraries.
Kim HS; Lo SC; Wear DJ; Stojadinovic A; Weina PJ; Izadjoo MJ
J Immunol Methods; 2011 Sep; 372(1-2):146-61. PubMed ID: 21787781
[TBL] [Abstract][Full Text] [Related]
40. T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes.
Lohmann T; Leslie RD; Londei M
J Autoimmun; 1996 Jun; 9(3):385-9. PubMed ID: 8816975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
